nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—HTR2A—nerve—acquired immunodeficiency syndrome	0.0138	0.0304	CbGeAlD
Oxymetazoline—HTR1E—nervous system—acquired immunodeficiency syndrome	0.0136	0.0301	CbGeAlD
Oxymetazoline—HTR1E—central nervous system—acquired immunodeficiency syndrome	0.0131	0.029	CbGeAlD
Oxymetazoline—NISCH—blood—acquired immunodeficiency syndrome	0.0123	0.0272	CbGeAlD
Oxymetazoline—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.0123	0.0271	CbGeAlD
Oxymetazoline—NISCH—bone marrow—acquired immunodeficiency syndrome	0.0119	0.0263	CbGeAlD
Oxymetazoline—NISCH—spinal cord—acquired immunodeficiency syndrome	0.0119	0.0262	CbGeAlD
Oxymetazoline—HTR2A—endothelium—acquired immunodeficiency syndrome	0.0117	0.0259	CbGeAlD
Oxymetazoline—NISCH—vagina—acquired immunodeficiency syndrome	0.0114	0.0252	CbGeAlD
Oxymetazoline—NISCH—lung—acquired immunodeficiency syndrome	0.0108	0.0239	CbGeAlD
Oxymetazoline—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.0104	0.023	CbGeAlD
Oxymetazoline—HTR1E—brain—acquired immunodeficiency syndrome	0.0104	0.023	CbGeAlD
Oxymetazoline—HTR2B—skin of body—acquired immunodeficiency syndrome	0.00939	0.0207	CbGeAlD
Oxymetazoline—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.00854	0.0189	CbGeAlD
Oxymetazoline—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.00835	0.0184	CbGeAlD
Oxymetazoline—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.00822	0.0181	CbGeAlD
Oxymetazoline—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.00804	0.0178	CbGeAlD
Oxymetazoline—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.00765	0.0169	CbGeAlD
Oxymetazoline—NISCH—brain—acquired immunodeficiency syndrome	0.00765	0.0169	CbGeAlD
Oxymetazoline—HTR2B—digestive system—acquired immunodeficiency syndrome	0.00751	0.0166	CbGeAlD
Oxymetazoline—NISCH—lymph node—acquired immunodeficiency syndrome	0.00739	0.0163	CbGeAlD
Oxymetazoline—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.00734	0.0162	CbGeAlD
Oxymetazoline—HTR2B—blood—acquired immunodeficiency syndrome	0.00715	0.0158	CbGeAlD
Oxymetazoline—HTR2B—vagina—acquired immunodeficiency syndrome	0.00663	0.0146	CbGeAlD
Oxymetazoline—ADRA1B—brain—acquired immunodeficiency syndrome	0.00653	0.0144	CbGeAlD
Oxymetazoline—HTR1B—nervous system—acquired immunodeficiency syndrome	0.00645	0.0142	CbGeAlD
Oxymetazoline—ADRA1D—brain—acquired immunodeficiency syndrome	0.00638	0.0141	CbGeAlD
Oxymetazoline—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.00628	0.0139	CbGeAlD
Oxymetazoline—HTR2B—lung—acquired immunodeficiency syndrome	0.00627	0.0138	CbGeAlD
Oxymetazoline—HTR1D—nervous system—acquired immunodeficiency syndrome	0.00624	0.0138	CbGeAlD
Oxymetazoline—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.00621	0.0137	CbGeAlD
Oxymetazoline—HTR2C—nervous system—acquired immunodeficiency syndrome	0.00618	0.0136	CbGeAlD
Oxymetazoline—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.00601	0.0133	CbGeAlD
Oxymetazoline—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.00595	0.0131	CbGeAlD
Oxymetazoline—ADRA1A—blood—acquired immunodeficiency syndrome	0.00591	0.013	CbGeAlD
Oxymetazoline—HTR2B—nervous system—acquired immunodeficiency syndrome	0.00581	0.0128	CbGeAlD
Oxymetazoline—HTR2A—retina—acquired immunodeficiency syndrome	0.00571	0.0126	CbGeAlD
Oxymetazoline—ADRA2C—blood—acquired immunodeficiency syndrome	0.00563	0.0124	CbGeAlD
Oxymetazoline—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.00559	0.0123	CbGeAlD
Oxymetazoline—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.00542	0.012	CbGeAlD
Oxymetazoline—ADRA2C—vagina—acquired immunodeficiency syndrome	0.00522	0.0115	CbGeAlD
Oxymetazoline—ADRA2C—lung—acquired immunodeficiency syndrome	0.00494	0.0109	CbGeAlD
Oxymetazoline—HTR1B—brain—acquired immunodeficiency syndrome	0.00493	0.0109	CbGeAlD
Oxymetazoline—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.0048	0.0106	CbGeAlD
Oxymetazoline—HTR1D—brain—acquired immunodeficiency syndrome	0.00477	0.0105	CbGeAlD
Oxymetazoline—HTR2C—brain—acquired immunodeficiency syndrome	0.00473	0.0104	CbGeAlD
Oxymetazoline—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.00462	0.0102	CbGeAlD
Oxymetazoline—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.00457	0.0101	CbGeAlD
Oxymetazoline—ADRA2A—blood—acquired immunodeficiency syndrome	0.00449	0.00992	CbGeAlD
Oxymetazoline—HTR2B—brain—acquired immunodeficiency syndrome	0.00444	0.0098	CbGeAlD
Oxymetazoline—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.0044	0.00972	CbGeAlD
Oxymetazoline—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.00433	0.00956	CbGeAlD
Oxymetazoline—HTR2B—lymph node—acquired immunodeficiency syndrome	0.00429	0.00947	CbGeAlD
Oxymetazoline—ADRA2A—vagina—acquired immunodeficiency syndrome	0.00416	0.0092	CbGeAlD
Oxymetazoline—HTR2A—digestive system—acquired immunodeficiency syndrome	0.00401	0.00885	CbGeAlD
Oxymetazoline—ADRA2A—lung—acquired immunodeficiency syndrome	0.00394	0.0087	CbGeAlD
Oxymetazoline—HTR2A—blood—acquired immunodeficiency syndrome	0.00382	0.00843	CbGeAlD
Oxymetazoline—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.00368	0.00813	CbGeAlD
Oxymetazoline—ADRA1A—brain—acquired immunodeficiency syndrome	0.00367	0.0081	CbGeAlD
Oxymetazoline—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.00365	0.00805	CbGeAlD
Oxymetazoline—HTR2A—vagina—acquired immunodeficiency syndrome	0.00354	0.00782	CbGeAlD
Oxymetazoline—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.00351	0.00775	CbGeAlD
Oxymetazoline—ADRA2C—brain—acquired immunodeficiency syndrome	0.00349	0.00771	CbGeAlD
Oxymetazoline—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.00338	0.00745	CbGeAlD
Oxymetazoline—HTR2A—lung—acquired immunodeficiency syndrome	0.00335	0.00739	CbGeAlD
Oxymetazoline—HTR2A—nervous system—acquired immunodeficiency syndrome	0.0031	0.00685	CbGeAlD
Oxymetazoline—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.00299	0.00659	CbGeAlD
Oxymetazoline—ADRA2A—brain—acquired immunodeficiency syndrome	0.00279	0.00616	CbGeAlD
Oxymetazoline—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.00269	0.00595	CbGeAlD
Oxymetazoline—HTR2A—brain—acquired immunodeficiency syndrome	0.00237	0.00523	CbGeAlD
Oxymetazoline—HTR2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000382	0.000698	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000379	0.000693	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000377	0.000689	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000376	0.000686	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000376	0.000686	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000376	0.000686	CbGpPWpGaD
Oxymetazoline—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000374	0.000684	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000374	0.000684	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000374	0.000684	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000371	0.000679	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000371	0.000679	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000367	0.00067	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000367	0.00067	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000366	0.000668	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000365	0.000668	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000365	0.000668	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000363	0.000663	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000359	0.000657	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000359	0.000657	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000359	0.000656	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000359	0.000656	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000359	0.000656	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000359	0.000656	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000357	0.000653	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000354	0.000647	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000352	0.000643	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000352	0.000643	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000352	0.000643	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000351	0.000642	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000349	0.000638	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000349	0.000638	CbGpPWpGaD
Oxymetazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000348	0.000637	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000347	0.000635	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000347	0.000634	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000347	0.000634	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000344	0.000629	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00034	0.000621	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00034	0.000621	CbGpPWpGaD
Oxymetazoline—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000339	0.00062	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000335	0.000613	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000334	0.00061	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000334	0.00061	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000333	0.000608	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000332	0.000606	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00033	0.000604	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00033	0.000602	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000328	0.000599	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000327	0.000597	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000327	0.000597	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000327	0.000597	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000326	0.000596	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000326	0.000596	CbGpPWpGaD
Oxymetazoline—HTR1E—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000326	0.000595	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000325	0.000594	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000325	0.000593	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000323	0.000591	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000323	0.00059	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000319	0.000584	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000319	0.000584	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000319	0.000583	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000318	0.000581	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000316	0.000577	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000315	0.000575	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000311	0.000569	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000311	0.000568	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00031	0.000566	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000306	0.000559	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000302	0.000552	CbGpPWpGaD
Oxymetazoline—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000302	0.000552	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000302	0.000551	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000301	0.000551	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000301	0.00055	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000301	0.00055	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000299	0.000546	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000299	0.000546	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000297	0.000544	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000297	0.000543	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000297	0.000542	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000297	0.000542	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000297	0.000542	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000296	0.00054	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000295	0.000539	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000293	0.000536	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000293	0.000535	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000293	0.000535	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000292	0.000535	CbGpPWpGaD
Oxymetazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000289	0.000529	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000286	0.000522	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000283	0.000518	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000281	0.000514	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000278	0.000508	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000276	0.000504	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000275	0.000503	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000275	0.000503	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000274	0.0005	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000273	0.0005	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000273	0.000499	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000272	0.000497	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000272	0.000497	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000271	0.000496	CbGpPWpGaD
Oxymetazoline—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	0.00027	0.000493	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000269	0.000492	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000269	0.000492	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000268	0.00049	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000268	0.000489	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000263	0.000482	CbGpPWpGaD
Oxymetazoline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000262	0.000479	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000261	0.000477	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000257	0.00047	CbGpPWpGaD
Oxymetazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000257	0.000469	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000256	0.000468	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000256	0.000468	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000254	0.000464	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000252	0.000461	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000252	0.000461	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00025	0.000458	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00025	0.000456	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000249	0.000454	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000248	0.000453	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000246	0.00045	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000246	0.00045	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000246	0.000449	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000245	0.000447	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000244	0.000447	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000243	0.000444	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000241	0.00044	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000239	0.000437	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000236	0.000431	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000231	0.000422	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000231	0.000422	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000229	0.000419	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000227	0.000416	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000227	0.000414	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000226	0.000413	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000226	0.000413	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000224	0.000409	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000224	0.000409	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000224	0.000409	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000223	0.000407	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000222	0.000406	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000222	0.000405	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000222	0.000405	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000222	0.000405	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000221	0.000403	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000219	0.000401	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000219	0.0004	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000216	0.000395	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000216	0.000394	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000216	0.000394	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000212	0.000388	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000212	0.000388	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000209	0.000382	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000206	0.000377	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000206	0.000377	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000205	0.000374	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000205	0.000374	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000205	0.000374	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000203	0.000372	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000203	0.000371	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000201	0.000367	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000201	0.000367	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.0002	0.000366	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000196	0.000359	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000195	0.000356	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000193	0.000352	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000193	0.000352	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000192	0.00035	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000189	0.000345	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000189	0.000345	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000189	0.000345	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000188	0.000344	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000186	0.000341	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000184	0.000337	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000176	0.000321	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000175	0.000321	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000175	0.00032	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000175	0.00032	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000175	0.000319	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000174	0.000318	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000173	0.000316	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000172	0.000313	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000171	0.000312	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000169	0.000308	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000166	0.000304	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000164	0.0003	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000164	0.000299	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000162	0.000296	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000162	0.000295	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000159	0.000291	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000159	0.000291	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000158	0.000289	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000157	0.000287	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000155	0.000283	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000152	0.000278	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000149	0.000272	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000148	0.00027	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000147	0.000268	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000146	0.000266	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000145	0.000264	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000144	0.000264	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000144	0.000262	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000142	0.00026	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000142	0.00026	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000141	0.000258	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000139	0.000255	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000133	0.000244	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000132	0.000241	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000131	0.00024	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000129	0.000236	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000129	0.000236	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000129	0.000236	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000126	0.000231	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	0.000126	0.00023	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.00012	0.00022	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000118	0.000216	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000118	0.000215	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000117	0.000215	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000116	0.000212	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000115	0.000211	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000109	0.000199	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000108	0.000198	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000103	0.000188	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	0.000102	0.000187	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000101	0.000185	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000101	0.000184	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.15e-05	0.000167	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.1e-05	0.000166	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.78e-05	0.000161	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.74e-05	0.00016	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.54e-05	0.000156	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.5e-05	0.000155	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.41e-05	0.000154	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.37e-05	0.000153	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.63e-05	0.000139	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.59e-05	0.000139	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.47e-05	0.000137	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.43e-05	0.000136	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.96e-05	0.000127	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.94e-05	0.000127	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.91e-05	0.000126	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.81e-05	0.000125	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.4e-05	0.000117	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.96e-05	0.000109	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.38e-05	9.83e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.16e-05	9.44e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.02e-05	9.18e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.94e-05	9.03e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.48e-05	8.2e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.39e-05	8.02e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.08e-05	7.46e-05	CbGpPWpGaD
